ScoreWhy is Nephrocare Health Services Ltd ?
1
The company is Net-Debt Free
2
Low Debt Company with Strong Long Term Fundamental Strength
3
With a growth in Net Profit of 15.34%, the company declared Very Positive results in Jun 26
- The company has declared positive results for the last 2 consecutive quarters
- OPERATING CF(Y) Highest at Rs 132.90 Cr
- NET SALES(Q) Highest at Rs 281.75 cr
- OPERATING PROFIT TO INTEREST(Q) Highest at 28.90 times
4
With ROE of 6.9, it has a Very Expensive valuation with a 6.7 Price to Book Value
- Over the past year, while the stock has generated a return of NA, its profits have risen by 15%
5
Falling Participation by Institutional Investors
- Institutional investors have decreased their stake by -0.75% over the previous quarter and collectively hold 17.83% of the company
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Nephrocare Healt should be less than 10%
- Overall Portfolio exposure to Healthcare Services should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Healthcare Services)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
No Data Found
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
3.39
Debt to EBITDA (avg)
0.35
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.84
Tax Ratio
20.52%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
17.83%
ROCE (avg)
17.70%
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
88
Industry P/E
67
Price to Book Value
6.68
EV to EBIT
52.17
EV to EBITDA
31.33
EV to Capital Employed
9.23
EV to Sales
7.12
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
17.70%
ROE (Latest)
6.88%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
RSI
No Signal
Bollinger Bands
Mildly Bullish
KST
Dow Theory
No Trend
Bullish
OBV
No Trend
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend22What is working for the Company
OPERATING CF(Y)
Highest at Rs 132.90 Cr
NET SALES(Q)
Highest at Rs 281.75 cr
OPERATING PROFIT TO INTEREST(Q)
Highest at 28.90 times
PAT(Q)
At Rs 31.97 cr has Grown at 66.4% (vs previous 4Q average
PBT LESS OI(Q)
Highest at Rs 33.57 cr.
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Nephrocare Healt
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 33.57 cr has Grown at 86.2% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 18.03 CrMOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Operating Cash Flow - Annually
Highest at Rs 132.90 Cr and Grown
each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (Rs Cr)
Net Sales - Quarterly
Highest at Rs 281.75 cr and Grown
each quarter in the last five quartersMOJO Watch
Near term sales trend is very positive
Net Sales (Rs Cr)
Operating Profit to Interest - Quarterly
Highest at 28.90 times
in the last five quartersMOJO Watch
The company's ability to manage interest payments is improving
Operating Profit to Interest
Profit After Tax (PAT) - Quarterly
At Rs 31.97 cr has Grown at 66.4% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 19.21 CrMOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 33.57 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
